VKTX: Total Utang marang Modal Viking Therapeutics, Inc.

Logo perusahaan publik Viking Therapeutics, Inc. (VKTX)

Viking Therapeutics (VKTX) specializes in developing innovative medications to combat obesity. The price action shown on this chart confirms the company's status as an innovative brand that has earned the recognition of the medical community. Brian Lian's team is demonstrating deep expertise as they prepare the product for commercial sale. Top-tier talent is attracted through generous stock options and large-scale grants, while the individual debt-to-equity ratio stands at 0.43.

VKTX - Total Utang marang Modal Viking Therapeutics, Inc. ing rentang 04.07.2022 - 01.11.2026

Rincian metrik lan analitis perusahaan Viking Therapeutics Corp (VKTX)

- rega lan prakiraan konsensus rega:
Bagan rega Viking Therapeutics, Inc.|VKTX - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Viking Therapeutics|VKTX - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Viking Therapeutics|VKTX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku vikingtherapeutics.com|VKTX - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Viking Therapeutics|VKTX - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Viking Therapeutics|VKTX - Utang perusahaan|Utang-utang marang kapitalisasi buku Viking Therapeutics|VKTX - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Viking Therapeutics|Rasio cepet vikingtherapeutics.com
- statistik bathi lan rasio pasar:
VKTX - Asil keuangan resik
Ringkesan analisis perusahaan:Viking Therapeutics, Inc., VKTX
Barang utama vikingtherapeutics.com

Investors must assess bankruptcy risk by analyzing the ratio of total liabilities to equity for Viking Therapeutics (VKTX). Given the high cost of clinical trials and the patent protection of molecules, changes in the business leverage ratio demonstrate the company's ability to fund development without critical dependence on borrowed capital, confirming financial stability and a low probability of liquidity gaps.

Analisis pesaing

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|SUPN - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Utang marang Ekuitas|Utang marang Modal Harmony Corp (HRMY)|Rasio Total Utang marang Ekuitas BHVN|Utang marang Ekuitas AMLX|Total Utang marang Modal TRVI|Koefisien Total Utang marang Modal Praxis Precision Medicines Inc|Utang marang Ekuitas Anavex Corp AVXL|Total Utang marang Modal CeriBell EEG CBLL|Prothena Corporation plc - Total Utang marang Modal|Koefisien Total Utang marang Modal Alector, Inc. ALEC|Annexon (ANNX) - Utang marang Ekuitas|Rasio Utang marang Ekuitas OMER|NGNE (Neurogene Corp) - Total Utang marang Modal|ACIU - Rasio Utang marang Modal|Rasio Total Utang marang Ekuitas VYGR (Voyager Therapeutics)|NMRA (neumoratx.com) - Rasio Kabeh Utang marang Dana Pribadi|Scilex - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal TVGN (Tevogen Bio Holdings Inc.)|Alpha Cognition Corp - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi CGTX (Cognition Therapeutics Inc.)|IKT: Total Utang marang Modal|Utang marang Modal cassavasciences.com (SAVA)|Utang marang Ekuitas Assertio Holdings|COYA: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal VTGN|Total Utang marang Modal ovidrx.com (OVID)|Utang marang Ekuitas Acumen Pharmaceuticals ABOS|CRVO (cervomed.com) - Utang Agregat marang Ekuitas|Alterity Therapeutics Ltd - Total Utang marang Modal|Utang marang Modal Clene Inc.|PEPG (pepgen.com) - Rasio Total Utang marang Ekuitas|Jupiter Neurosciences, Inc. (JUNS) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas RLMD|ANVS (annovisbio.com) - Utang Agregat marang Modal|Total Utang marang Modal GRCE|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc.|Total Utang marang Modal KLTO (Klotho Neurosciences)|NRSN - Rasio Total Utang marang Ekuitas|RVPH - Utang marang Ekuitas|Koefisien Total Utang marang Modal MetaVia Inc MTVA|NRXS (NeurAxis) - Rasio Total Utang marang Ekuitas|HSDT (Helius Medical Technologies) - Utang marang Ekuitas|Utang marang Ekuitas Passage Bio Inc.|Total Utang marang Modal Neuphoria|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|Utang Agregat marang Modal ATHA|Addex Therapeutics Ltd - Rasio Total Utang marang Ekuitas|ALZN: Rasio Utang marang Ekuitas|CYCN - Utang marang Ekuitas|PTIX (Protagenic Therapeutics) - Rasio Utang marang Ekuitas|KTTA: Total Utang marang Modal|Utang marang Modal Cortigent (CRGT)|Rasio Total Utang marang Ekuitas ATXI|Total Utang marang Modal Brainstorm Cell Therapeutics Inc.|Utang marang Ekuitas Cara Therapeutics, Inc (CARA)|CHRO (Chromocell) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Eliem Therapeutics Inc. ELYM|Intra-Cellular Therapies Inc. (ITCI) - Utang marang Modal|LBPH: Rasio Total Utang marang Ekuitas|MRNS: Utang marang Ekuitas|NKGN: Total Utang marang Modal|NRBO - Koefisien Total Utang marang Modal|Utang marang Ekuitas Sage Therapeutics, Inc.|Total Utang marang Modal synaptogen.com|Total Utang marang Modal TRVN|Koefisien Total Utang marang Modal vigilneuro.com|Utang marang Ekuitas Anew Medical WENA|CERE: Rasio Utang marang Ekuitas